Glenmark Generics receives approval for Rizatriptan Benzoate tabs
According to IMS Health for the 12-month period ending March 2013, Rizatriptan ODT achieved sales of $263 million
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
M&A activity in pharma sector focuses on strengthening respiratory portfolio
Decreases in both volume and value terms, when compared to the average of previous six months
Bangalore INDIA NANO focus: Drug delivery and healthcare
6th edition of the event to be held from December 4-6, 2013
Noppen Conference & Exhibition to host 2nd Annual India Pharmaceutical Summit
Event to be held in Mumbai on October 10-11, 2013
Sinhgad College of Pharmacy organises faculty development programme
AICTE-sponsored programme to be held till July 27, 2013
Wooing Indian pharma back
Stringent regulations and ever increasing approval timelines are hampering the India pharma story, though recent recommendations…
IPA to partner with state pharmacist associations
Associations from Karnataka, Kerala and Goa to be affiliated by end July
Cipla India completes deal with Cipla Medpro South Africa
The acquisition aims to strengthen Cipla’s commitment to South Africa and the broader African continent
Ranbaxy’s anti-malaria drug Synriam wins Innovation Award
The drug is used for the treatment of plasmodium falciparum malaria, in adults
Glenmark confirms patent challenge for its generic versions of VIMPAT in the US
Glenmark’s ANDA products are generic versions of VIMPAT, which are indicated for an adjunctive therapy in the treatment for…